Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.
NCT07564895
·
clinicaltrials.gov ↗
COMPLETED
Status
841
Enrollment
OTHER
Sponsor class
Conditions
Ulcerative Colitis (UC)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University